Brian Block, MD
Pain Medicine · Baltimore, MDNPI 1326004433
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,142 of the $7,382 with a category attached, or 69.6%. It is spread thinly across 39 manufacturers, the largest accounting for just 21.8%. Reporting peaked in 2019 at $2,160 and has fallen 66.6% since, to $721 in 2025.
Across 161 payments — averaging $45.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- MML US, Inc.$1K
- Abbott$702
- Nevro Corp.$696
- Vertos Medical, Inc.$580
- Pacira Pharmaceuticals Incorporated$450
- plus $2K from 33 others
Across 17 payments — averaging $1937.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$27K
- Globus Medical$6K
What the payments were for
- Speaking & faculty fees$4506%
- Travel & lodging$1,79124%
- Food & beverage$5,14270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 31 | $1,608 |
| MML US, Inc. | 17 | $1,428 |
| Abbott | 14 | $702 |
| Nevro Corp. | 13 | $696 |
| Vertos Medical, Inc. | 16 | $580 |
| Pacira Pharmaceuticals Incorporated | 1 | $450 |
| SPR Therapeutics, Inc | 3 | $405 |
| Amgen(2 entities) | 14 | $182 |
| Biotronik NRO, Inc. | 4 | $182 |
| Relievant Medsystems, Inc. | 1 | $146 |
| Globus Medical | 5 | $138 |
| Saluda Medical Americas, Inc. | 5 | $134 |
| Scilex Pharmaceuticals Inc. | 8 | $132 |
| Convatec Inc. | 1 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| Pacira Therapeutics, Inc. | 2 | $41 |
| Fidia Pharma USA Inc. | 1 | $37 |
| MDD US Operations, LLC | 1 | $28 |
| Lilly USA, LLC | 2 | $27 |
| Stryker | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $22 |
| Vertex | 1 | $22 |
| Novartis | 1 | $21 |
| Medtronic | 1 | $21 |
| Spinal Simplicity, LLC | 1 | $21 |
| Assertio Therapeutics, Inc. | 1 | $20 |
| AbbVie | 1 | $18 |
| Upsher-smith Laboratories LLC | 1 | $18 |
| Tonix Medicines, Inc. | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Kaleo, Inc. | 1 | $15 |
| Shionogi Inc | 1 | $15 |
| International Rehabilitative Sciences, Inc | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Electronic Waveform Lab, Inc. | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Zimmer Biomet | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ReActiv8$1,150
- SPECTRA WAVEWRITER$971
- EXPAREL$450
- SPRINT PNS System$354
- ETERNA$309
- Intracept$292
- mild Device Kit$282
- Senza$257
- Proclaim Family of SCS IPGs$188
- Omnia$151
- Prospera$132
- GENERAL PAIN MANAGEMENT$117
How this compares
$7,382 in reported general payments places this provider in the 75th percentile of 144 pain medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 13 | $8,490 |
| Buprenorphine | 22 | $4,478 |
| Gabapentin | 103 | $1,778 |
| Pregabalin | 52 | $1,150 |
| Duloxetine Hcl | 50 | $1,067 |
| Celecoxib | 26 | $807 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $680 |
| Oxycodone Hcl | 38 | $601 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $359 |
| Tizanidine Hcl | 26 | $279 |
| Cyclobenzaprine Hcl | 14 | $276 |
| Tramadol Hcl | 38 | $128 |
| Meloxicam | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Baltimore
- Randy DavisBaltimore$169K
- Paul ChristoBaltimore$137K
- Behnam JafarpourBaltimore$45K
- David MaineBaltimore$24K
- Jay KarriBaltimore$14K
- Avni GuptaBaltimore$12K
- Anuragh TrikhaBaltimore$9K
- Benjamin Fujita-HowieBaltimore$6K
- William RaoofiBaltimore$5K
- Terri BlumeBaltimore$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.